Zobrazeno 1 - 10
of 575
pro vyhledávání: '"immunoglobulin replacement therapy"'
Autor:
Esra Karabiber
Publikováno v:
Haseki Tıp Bülteni, Vol 62, Iss 4, Pp 235-242 (2024)
Aim: Patients with inborn errors of immunity (IEI) have a higher frequency of infections and long-term antibiotic usage. We aimed to assess the effects of immunoglobulin replacement therapy (IgRT) on infection rates, antibiotic usage, and treatment o
Externí odkaz:
https://doaj.org/article/e17ae0ba9f844216bfc919e3a442e4f6
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
Seasonal and pandemic influenza infection present a potential threat to patients with antibody deficiency. The acceptance and effect of the current recommendation for annual vaccination against influenza for patients with antibody deficiency is not w
Externí odkaz:
https://doaj.org/article/d9869629cab9409788bc347c78da28e6
Autor:
Thure Mors Haunstrup, MD, Kaspar René Nielsen, MD, PhD, Sys Hasslund, MD, PhD, Line Lindgreen Eriksen, PhD, Jakob T. Bay, MD, PhD, John Baech, MD, PhD, Rudi Steffensen, PhD, Lisbeth Venø Kruse, MD, PhD
Publikováno v:
Journal of Allergy and Clinical Immunology: Global, Vol 3, Iss 3, Pp 100274- (2024)
The clinical presentation of CD21 deficiency in 2 siblings caused by a novel mutation in the CD21 gene is reported, and the frequency of this mutation in the Danish population is explored. Successful treatment with IgG replacement in both patients wi
Externí odkaz:
https://doaj.org/article/674f8b59263045dbb165459ac2bf503a
Autor:
Swarn Arya, Zainab Shahid
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
Chimeric antigen receptor-modified T cell (CAR T-cell) therapy has revolutionized the management of hematological malignancies. In addition to impressive malignancy-related outcomes, CAR T-cell therapy has significant toxicity-related adverse events,
Externí odkaz:
https://doaj.org/article/be61085824aa40cabb673de713c34e14
Autor:
Luciana del Campo Guerola, Ana Andrea García Sacristán, Antonio Portolés, Maricruz Jasso, Teresa Guerra-Galán, Eduardo de la Fuente-Munoz, María Palacios-Ortega, Miguel Fernández-Arquero, Cristina Cuesta-Mínguez, Aránzazu Rodríguez-Sanz, Ascensión Peña-Cortijo, Marta Polo, Marta Mateo Morales, Eduardo Anguita-Mandly, Teresa Benítez Jiménez, Celina Benavente Cuesta, Silvia Sánchez-Ramón
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
This is the first report of the health economic benefits derived from preventing infections through Immunoglobulin Replacement Therapy (IgRT) in patients with secondary immunodeficiency due to hematological malignancies. We conducted a retrospective
Externí odkaz:
https://doaj.org/article/0f71c95202484eca8f9dda9b12012b6b
Autor:
Samya Van Coillie, Johan Prévot, Silvia Sánchez-Ramón, David M. Lowe, Michael Borg, Brigitte Autran, Gesmar Segundo, Antonio Pecoraro, Nicolas Garcelon, Cornelis Boersma, Susana L. Silva, Jose Drabwell, Isabella Quinti, Isabelle Meyts, Adli Ali, Siobhan O. Burns, Martin van Hagen, Martine Pergent, Nizar Mahlaoui
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
The International Patient Organisation for Primary Immunodeficiencies (IPOPI) held its second Global Multi-Stakeholders’ Summit, an annual stimulating and forward-thinking meeting uniting experts to anticipate pivotal upcoming challenges and opport
Externí odkaz:
https://doaj.org/article/a360c4410d354f929b13dc536d9cc795
Autor:
Megan Harmon, Kiarash Riazi, Jeannie Callum, Donald M. Arnold, Rebecca Barty, Davinder Sidhu, Nancy M. Heddle, Laurie MacLeod, Na Li
Publikováno v:
Allergy, Asthma & Clinical Immunology, Vol 19, Iss 1, Pp 1-15 (2023)
Abstract Background Canada has high immunoglobulin (IG) product utilization, raising concerns about appropriate utilization, cost and risk of shortages. Currently, there is no national set of standardized IG guidelines, and considerable variations ex
Externí odkaz:
https://doaj.org/article/d1708bdec9d5409a8a4f8ac7336152fa
Autor:
Maria Dimou, Mohamed Abuzakouk, Mona Al Ahmad, Khalil Al Farsi, Ahmad Alhuraiji, Fayhan Al Roqi, Ahmed Alsaeed, Mohsen Alzahrani, Ali Bazarbachi, Honar Cherif, Riad El Fakih, Carla Irani, Faraz Khan, Iman Nasr, Hani Yousif Osman, Mustaqeem Siddiqui
Publikováno v:
Frontiers in Hematology, Vol 3 (2024)
Secondary immunodeficiency (SID), acquired hypogammaglobinemia, is an immunodeficiency caused by different factors like diseases, medications, and/or nutrition disorders. Most patients with hematological malignancies (HM), namely chronic lymphocytic
Externí odkaz:
https://doaj.org/article/910f89a4edfc45c88e4660e8bea0de50
Publikováno v:
Turkish Journal of Hematology, Vol 41, Iss 1, Pp 51-52 (2024)
Externí odkaz:
https://doaj.org/article/0c38cd7745ac4bef98f8307947058a15
Autor:
Jonathan Cutajar, MB BChir, Effrossyni Gkrania-Klotsas, MD, PhD, Clare Sander, BM BChr, Andres Floto, MB BChir, PhD, Anita Chandra, MB BChir, Ania Manson, MB BChB(Hons), PhD, Dinakantha Kumararatne, MB BS, PhD
Publikováno v:
Journal of Allergy and Clinical Immunology: Global, Vol 2, Iss 4, Pp 100133- (2023)
Background: Antibody deficiencies result from reduced immunoglobulin levels and function, increasing susceptibility to, primarily, bacterial infection. Primary antibody deficiencies comprise intrinsic defects in B-cell physiology, often due to inheri
Externí odkaz:
https://doaj.org/article/5d80dd5bc1d544dca8b2e8dec059cb52